Your browser doesn't support javascript.
loading
Clinical Outcomes of Patients With Chronic Myeloid Leukemia With Concurrent Core Binding Factor Rearrangement and Philadelphia Chromosome.
Morita, Kiyomi; Jabbour, Elias; Ravandi, Farhad; Borthakur, Gautam; Khoury, Joseph D; Hu, Shimin; Garcia-Manero, Guillermo; Wierda, William; Issa, Ghayas; Daver, Naval; Pemmaraju, Naveen; Montalban-Bravo, Guillermo; Soltysiak, Kelly A; Pierce, Sherry; Bueso-Ramos, Carlos; Cortes, Jorge; Sasaki, Koji.
Affiliation
  • Morita K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Khoury JD; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Hu S; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Wierda W; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Issa G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Soltysiak KA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Pierce S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Bueso-Ramos C; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Cortes J; Georgia Cancer Center, Augusta, GA.
  • Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: ksasaki1@mdanderson.org.
Clin Lymphoma Myeloma Leuk ; 21(5): 338-344, 2021 05.
Article in En | MEDLINE | ID: mdl-33597098

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Core Binding Factors Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2021 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Core Binding Factors Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Clin Lymphoma Myeloma Leuk Journal subject: NEOPLASIAS Year: 2021 Type: Article